INS and Hypoglycemia: In conclusion, the present study provides evidence that metformin is as effective as insulin for glycemic control in GDM and is superior with respect to the prevention of adverse neonatal outcomes, such as neonatal hypoglycemia, macrosomia, and NICU admission.